CNSX:SNNSunniva Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sunniva Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range$0.13MA: $0.19▼$0.2552-Week Range N/AVolume13,689 shsAverage Volume44,398 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesOptions Chain Sunniva Inc., through its subsidiaries, operates as a vertically integrated medical cannabis company in California and Canada. The company focuses on producing medical cannabis; and converting trim to extracted products, such as cannabis oil. It also owns and operates a network of 7 clinics in Canada specializing in medical cannabis; and provides custom, private-label vaporizers serving approximately 80 brands in the North American marketplace. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Sunniva. Previous Next 2.8 Community Rank Outperform VotesSunniva has received 73 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSunniva has received 56 “underperform” votes. (Add your “underperform” vote.)Community SentimentSunniva has received 56.59% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sunniva and other stocks. Vote “Outperform” if you believe SNN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SNN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSunniva does not currently pay a dividend.Dividend GrowthSunniva does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sunniva insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.56 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolCNSX:SNN Previous Symbol CUSIPN/A CIKN/A Webhttp://www.sunniva.com/ Phone1-866-SUNNIVADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees101 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive SNN News and Ratings via Email Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. TSXV:SNN Rates by TradingView Sunniva (CNSX:SNN) Frequently Asked Questions Has Sunniva been receiving favorable news coverage? News articles about SNN stock have trended very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sunniva earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutSunniva. Who are some of Sunniva's key competitors? Some companies that are related to Sunniva include Cannabix Technologies (BLO), Cochlear (CHEOF), COCHLEAR LTD/ADR (CHEOY), Ellex Medical Lasers (ELXMF), GN Store Nord A/S (GGNDF), Ion Beam Applications (IOBCF), Micro-X (MX1), MRI Interventions (CLPT), Neuroone Medical Technologies (NMTC), Ortho Regenerative Technologies (ORTH), PetVivo (PETV), Rafina Innovations (VICA), Sartorius Stedim Biotech (DIM), Uscom (UCM) and Viemed Healthcare (VMD). What other stocks do shareholders of Sunniva own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sunniva investors own include Canopy Growth (WEED), Energous (WATT), Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (CGC), Aurora Cannabis (ACB), CanniMed (CMED), CannTrust (CTST), Innovative Industrial Properties (IIPR) and CannaRoyalty (CNNRF). Who are Sunniva's key executives? Sunniva's management team includes the following people: Dr. Anthony F. Holler, Co-founder, CEO & Chairman (Age 67)Mr. Leith Pedersen, Founder, Pres, Chief Strategy Officer & Director (Age 47)Mr. Duncan Gordon, Chief Operating Officer (Age 55)Mr. David Negus C.A., CPA, Chief Financial Officer (Age 52)Mr. Benjamin Rootman, Gen. Counsel & Corp. Sec. (Age 41) What is Sunniva's stock symbol? Sunniva trades on the CNSX under the ticker symbol "SNN." How do I buy shares of Sunniva? Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Sunniva's official website? The official website for Sunniva is http://www.sunniva.com/. How can I contact Sunniva? Sunniva's mailing address is Suite 400, 355 – 4th Avenue S.W. Calgary, AB T2P 0J1. The company can be reached via phone at 1-866-SUNNIVA. This page was last updated on 4/8/2020 by MarketBeat.com StaffFeatured Article: What are the Different Types of Leveraged Buyouts?
